<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Reported-in-Senate" dms-id="A1" public-private="public">
	<form>
		<distribution-code display="yes">II</distribution-code>
		<calendar>Calendar No. 120</calendar>
		<congress>112th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 409</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20110217">February 17, 2011</action-date>
			<action-desc><sponsor name-id="S270">Mr. Schumer</sponsor> (for
			 himself, <cosponsor name-id="S243">Mr. Kyl</cosponsor>,
			 <cosponsor name-id="S209">Mr. Kohl</cosponsor>, <cosponsor name-id="S261">Mr.
			 Sessions</cosponsor>, <cosponsor name-id="S221">Mrs. Feinstein</cosponsor>,
			 <cosponsor name-id="S316">Mr. Whitehouse</cosponsor>, <cosponsor name-id="S311">Ms. Klobuchar</cosponsor>, <cosponsor name-id="S332">Mr.
			 Franken</cosponsor>, <cosponsor name-id="S341">Mr. Blumenthal</cosponsor>,
			 <cosponsor name-id="S307">Mr. Brown of Ohio</cosponsor>,
			 <cosponsor name-id="S309">Mr. Casey</cosponsor>, <cosponsor name-id="S166">Mr.
			 Lautenberg</cosponsor>, <cosponsor name-id="S338">Mr. Manchin</cosponsor>,
			 <cosponsor name-id="S247">Mr. Wyden</cosponsor>, and <cosponsor name-id="S057">Mr. Leahy</cosponsor>) introduced the following bill; which was
			 read twice and referred to the
			 <committee-name added-display-style="italic" committee-id="SSJU00" deleted-display-style="strikethrough">Committee on the
			 Judiciary</committee-name></action-desc>
		</action>
		<action stage="Reported-in-Senate">
			<action-date date="20110728">July 28, 2011</action-date>
			<action-desc>Reported by <sponsor name-id="S057">Mr. Leahy</sponsor>,
			 without amendment</action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To ban the sale of certain synthetic
		  drugs.</official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one"><enum>1.</enum><header>Short
			 title</header><text display-inline="no-display-inline">This Act may be cited as
			 the <quote><short-title>Combating Dangerous Synthetic
			 Stimulants Act of 2011</short-title></quote>.</text>
		</section><section id="id0DD7C5106B884549B3DFEE71B2DC493A"><enum>2.</enum><header>Controlled
			 Substances Act</header><text display-inline="no-display-inline">Schedule I of
			 section 202(c) of the Controlled Substances Act (21 U.S.C. 812(c)) is amended
			 in subsection (c) by adding at the end the following:</text>
			<quoted-block display-inline="no-display-inline" id="idCA2721A63AD34D25B4F0DEFAFA68C027" style="OLC">
				<paragraph id="idFF0B3DA261B14A36BFA96982EC5AEFDD"><enum>(18)</enum><text display-inline="yes-display-inline">4-methylmethcathinone (Mephedrone).</text>
				</paragraph><paragraph id="id03886D02BBEA46EC8BD65BF86C460524"><enum>(19)</enum><text>3,4-methylenedioxypyrovalerone
				(MDPV).</text>
				</paragraph><after-quoted-block>.</after-quoted-block></quoted-block>
		</section></legis-body>
	<endorsement>
		<action-date>July 28, 2011</action-date>
		<action-desc>Reported without amendment</action-desc>
	</endorsement>
</bill>
